Forte Biosciences, Inc. ( (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced its full year 2025 financial results and ...

A majority of CKD patients present with cellular inflammation and immunoparalysis predose --Gemini durably normalizes ...

Aptose Biosciences Inc. APTOF) on Tuesday reported a loss of $7.8 million in its fourth quarter. The Toronto-based company said it had a loss of $3.07 per share.

View Artelo Biosciences Inc ARTL stock quote prices, financial information, real-time forecasts, and company news from CNN.

Artelo Biosciences, Inc. ARTL shares are trading higher Friday after the company announced the withdrawal of its SEC ...

Pacira BioSciences Inc. (NASDAQ:PCRX) is one of the 7 best small-cap drug manufacturing stocks to buy according to hedge ...

Sagimet Biosciences Inc. (NASDAQ:SGMT) earns a place on our list of the top 10 stocks under $5 that could triple. As of March ...

Artelo Biosciences, Inc. (Nasdaq: ARTL) today announced the closing of its previously announced private placement of 3,188 ...

Discusses Clinical Utility and Evidence Supporting DecisionDx Melanoma Test and DECIDE Study March 23, 2026 4:30 ...

March 19, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences ...

Octave Bioscience, Inc. is a commercial stage precision care company pioneering biomarker-driven solutions for neurodegenerative diseases, with initial focus on Multiple Sclerosis, and Parkinson’s ...